Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2008-A00741-54 | Other Identifier | ANSM |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The investigators hypothesize that incidence of pharyngolaryngeal postoperative pain caused by the I-gel and LMA-Suprême devices will be ⤠5%
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| LMA-UNIQUE⢠| Active Comparator |
| |
| LMA-SUPREME⢠| Active Comparator |
| |
| I-GELĀ® | Active Comparator |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Insertion of LMA-UNIQUE(TM) device | Procedure | LMA-UNIQUE(TM) single-use adult supraglottic airway device inserted during short general anesthesia under controlled ventilation |
|
| Measure | Description | Time Frame |
|---|---|---|
| Incidence of pharyngolaryngeal postoperative pain of the three devices | Sore throat Y/N | 24 hours |
| Measure | Description | Time Frame |
|---|---|---|
| Pharyngolaryngeal postoperative pain between groups | Sore throat Y/N | 2 hours |
| Time taken to place device | From first attempt at introduction until acceptable exhaled CO2 curve attained (seconds) |
Not provided
Inclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Joƫl L'Hermite, MD | CHU Nimes | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| CHU Nimes | NƮmes | 30029 | France |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 27755181 | Result | L'Hermite J, Dubout E, Bouvet S, Bracoud LH, Cuvillon P, Coussaye JE, Ripart J. Sore throat following three adult supraglottic airway devices: A randomised controlled trial. Eur J Anaesthesiol. 2017 Jul;34(7):417-424. doi: 10.1097/EJA.0000000000000539. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Insertion of LMA-SUPREME(TM) device | Procedure | LMA-SUPREME(TM) single-use adult supraglottic airway device inserted during short general anesthesia under controlled ventilation |
|
| Insertion of I-GEL(R) device | Procedure | I-GEL(R) single-use adult supraglottic airway device inserted during short general anesthesia under controlled ventilation |
|
| End of surgery (maximum 2 hours) |
| Number of attempts needed to place device | End of surgery (maximum 2 hours) |
| Necessity of altering the size of the device | Y/N | End of surgery (maximum 2 hours) |
| Any patient movement during procedure | Y/N | End of surgery (maximum 2 hours) |
| Difficulty of insertion | 5-point scale: very easy-failure | End of surgery (maximum 2 hours) |
| Total leakage pressure of the devices | measured directly by the respirator | End of surgery (maximum 2 hours) |
| Ventilatory pressure of the devices | End of surgery (maximum 2 hours) |
| Device stability during surgery | Need to change the management system airways (orotracheal intubation or others) Y/N | End of surgery (maximum 2 hours) |
| Difficulty of device removal | 4-point scale: very easy-very difficult | End of surgery (maximum 2 hours) |